Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective

References

• Handke M, Harloff A, Bode C, et al. Patent foramen ovale and cryptogenic stroke: a matter of age? Semin Thromb Hemost. 2009;35:505–514.
   PubMed Web of Science ®Google Scholar
• Handke M, Harloff A, Olschewski M, et al. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357:2262–2268.
   PubMed Web of Science ®Google Scholar
• Bedeir K, Volpi J, Ramlawi B. Cryptogenic stroke with a patent foramen ovale: Medical therapy, percutaneous intervention, or surgery. J Card Surg. 2016;31:156–160.
   PubMed Web of Science ®Google Scholar
• Di Tullio MR. Patent foramen ovale: echocardiographic detection and clinical relevance in stroke. J Am Soc Echocardiogr. 2010;23:144–155. quiz 220.
   PubMed Web of Science ®Google Scholar
• Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:2160–2236.
   PubMed Web of Science ®Google Scholar
• Li J, Liu J, Liu M, et al. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack. Cochrane Database Syst Rev. 2015;9:CD009938.
   Google Scholar
• Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology. 1996;46:1301–1305.
   PubMed Web of Science ®Google Scholar
• Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke. 1997;28:2376–2381.
   PubMed Web of Science ®Google Scholar
• Sondergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377:1033–1042.
   PubMed Web of Science ®Google Scholar
• Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377:1022–1032.
   PubMed Web of Science ®Google Scholar
• Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377:1011–1021.
   PubMed Web of Science ®Google Scholar
• Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol. 2018;71:2335–2342.
   PubMed Web of Science ®Google Scholar
• Pickett CA, Villines TC, Ferguson MA, et al. Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale. Am J Cardiol. 2014;114:1584–1589.
   PubMed Web of Science ®Google Scholar
• Tirschwell DL, Turner M, Thaler D, et al. Cost-effectiveness of percutaneous patent foramen ovale closure as secondary stroke prevention. J Med Econ. 2018;21:1–10.
   PubMed Web of Science ®Google Scholar
• Leppert MH, Poisson SN, Carroll JD, et al. Cost-effectiveness of patent foramen ovale closure versus medical therapy for secondary stroke prevention. Stroke. 2018;49:1443–1450.
   PubMed Web of Science ®Google Scholar
• Kasner SE, Thomassen L, Sondergaard L, et al. Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study. Int J Stroke. 2017;12:998–1004.
   PubMed Web of Science ®Google Scholar
• W. L. Gore and Associates. Health data on file. Newark, DE: W.L. Gore and Associates Company; 2017.
   Google Scholar
• Johnson BH, Bonafede MM, Watson C. Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke. Clinicoecon Outcomes Res. 2016;8:53–61.
   PubMed Web of Science ®Google Scholar
• Amarenco P, Lavallee PC, Labreuche J, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374:1533–1542.
   PubMed Web of Science ®Google Scholar
• Luengo-Fernandez R, Gray AM, Bull L, et al. Quality of life after TIA and stroke: ten-year results of the Oxford Vascular Study. Neurology. 2013;81:1588–1595.
   PubMed Web of Science ®Google Scholar
• Post PN, Stiggelbout AM, Wakker PP. The utility of health states after stroke: a systematic review of the literature. Stroke. 2001;32:1425–1429.
   PubMed Web of Science ®Google Scholar
• Tengs TO, Lin TH. A meta-analysis of quality-of-life estimates for stroke. Pharmacoeconomics. 2003;21:191–200.
   PubMed Web of Science ®Google Scholar
• Health Economic Resource Center (HERC). What is cost-effectiveness analysis? [cited 2018 Aug 30]. Available from: https://www.herc.research.va.gov/include/page.asp?id=cost-effectiveness-analysis.
   Google Scholar
• Centers for Medicare & Medicaid Services. Medicaid costs. [cited 2018 Aug 30]. Available from: https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2018-02-14/ke5k-twun.
   Google Scholar
• cms.gov. Centers for Medicare and Medicaid Services [website]. [cited 2018 Aug 30]. Available from: https://www.cms.gov/.
   Google Scholar
• Woods B, Revill P, Sculpher M, et al. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. 2016;19:929–935.
   PubMed Web of Science ®Google Scholar
• Joo H, George MG, Fang J, et al. A literature review of indirect costs associated with stroke. J Stroke Cerebrovasc Dis. 2014;23:1753–1763.
   PubMed Web of Science ®Google Scholar
• Demaerschalk BM, Hwang HM, Leung G. US cost burden of ischemic stroke: a systematic literature review. Am J Manag Care. 2010;16:525–533.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603.
   PubMed Web of Science ®Google Scholar
• Brown DL, Boden-Albala B, Langa KM, et al. Projected costs of ischemic stroke in the United States. Neurology. 2006;67:1390–1395.
   PubMed Web of Science ®Google Scholar